Evidence map›Paper›PMID 26213561›Full record

ArticleFuture virology2015

HSV-I and the cellular DNA damage response.

Samantha Smith, Sandra K Weller

Abstract read
In one paragraph

Article in Future virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Samantha SmithDepartment of Molecular Biology & Biophysics, University of Connecticut Health Center, Farmington, CT 06030, USA.
Sandra K WellerDepartment of Molecular Biology & Biophysics, University of Connecticut Health Center, Farmington, CT 06030, USA.
UConn Health · US

Funding

GENETICS OF HSV DNA REPLICATIONR01AI021747 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WELLER, SANDRA K, WRIGHT, DENNIS L. · 1985 to 2024
$9.9M
GENETICS OF HSV DNA REPLICATIONR37AI021747 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WELLER, SANDRA K · 1998 to 2007
$3.3M
Role of viral and cellular recombination proteins in HSV DNA replicationR01AI069136 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WELLER, SANDRA K · 2006 to 2016
$3.1M
HSV1 PROCESSING/PACKAGING GENESR01AI037549 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI WELLER, SANDRA K · 1995 to 2010
$2.7M
NIAID NIH HHS R01 AI021747NIAID NIH HHS R01 AI037549NIAID NIH HHS R01 AI069136NIAID NIH HHS R37 AI021747
6 · The paper itself

Abstract

Peter Wildy first observed genetic recombination between strains of HSV in 1955. At the time, knowledge of DNA repair mechanisms was limited, and it has only been in the last decade that particular DNA damage response (DDR) pathways have been examined in the context of viral infections. One of the first reports addressing the interaction between a cellular DDR protein and HSV-1 was the observation by Lees-Miller

Indexed as

classic nonhomologous end-joiningC-NHEJDDRDNA damage responseHerpes simplex virus 1homologous recombinationHRHSV-1intrinsic antiviral defensemicrohomology-mediated end joiningMMEJsingle-strand annealingSSAvirally encoded recombinasevirus–host interactions

Identifiers

PMID26213561
PMCPMC4508672
OpenAlexW2155374876

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.